Lv11
68 积分 2025-02-24 加入
Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys
2天前
已完结
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
2个月前
已完结
A STUB1-CHIC2 complex inhibits CD8
2个月前
已完结
Natural killer cell therapies
2个月前
已完结
Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR-TKIs in non-small lung cancer
8个月前
已完结
皖公网安备34019202002308
